NORWALK, Conn., Aug. 14, 2026 /PRNewswire/ -- (NYSE: BMNR; BMNP) Bitmine Immersion Technologies, Inc. ("Bitmine" or the "Company") announced today that its Board of Directors has declared seventeen cash dividends...

The creative lifestyle brand now brings joyful, accessible art to families across America and around the world LOS ANGELES, Aug. 14, 2026 /PRNewswire/ -- Grabie, the creative lifestyle brand dedicated...

Class of 2030 brings experience from social services, population health, traditional Chinese medicine, engineering and the arts to Singapore's only graduate-entry medical school Duke-NUS welcomes 78 aspiring doctors at its...

SINGAPORE, Aug. 14, 2026 /PRNewswire/ -- Lapakgaming, a leading gaming and entertainment top-up platform, has officially rebranded as Joytify in Malaysia. The rebrand introduces an upgraded user experience featuring faster...

SINGAPORE, Aug. 14, 2026 /PRNewswire/ -- Lapakgaming, a leading gaming and entertainment top-up platform, has officially rebranded as Joytify in Malaysia. The rebrand introduces an upgraded user experience featuring faster...

BANGKOK, Aug. 14, 2026 /PRNewswire/ -- Delta Electronics (Thailand) Public Company Limited, a global leader in power management and smart green solutions, hosted the Delta Future Industry Summit 2026 under the...

BANGKOK, Aug. 14, 2026 /PRNewswire/ -- Delta Electronics (Thailand) Public Company Limited, a global leader in power management and smart green solutions, hosted the Delta Future Industry Summit 2026 under the...

PHUKET, Thailand, Aug. 14, 2026 /PRNewswire/ -- From the first coffee of the morning to cocktails under the stars, Courtyard by Marriott Phuket, Patong Beach Resort invites guests to discover nine...

PHUKET, Thailand, Aug. 14, 2026 /PRNewswire/ -- From the first coffee of the morning to cocktails under the stars, Courtyard by Marriott Phuket, Patong Beach Resort invites guests to discover nine...

SHANGHAI, Aug. 14, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug Administration (FDA) has approved ziresovir (AK0529) for a phase II clinical...